Novartis Prize for therapy-relevant pharmacological research

Pharmacological basic research and clinical application of drugs belong closely together if the respective research activities are oriented towards the overriding objective of therapeutic progress. Nevertheless, constant efforts are needed to ensure that both disciplines develop together. For this reason, the Novartis Foundation for Therapeutic Research, in collaboration with the German Society for Experimental and Clinical Pharmacology (Deutsche Gesellschaft für experimentelle und klinische Pharmakologie e.V.), awards the following grants to therapeutic researchers (DGPT), the Novartis Prize for therapy-relevant pharmacological research. This prize, endowed with 10,000 EUR, is intended to honor work that bridges the gap between pharmacological and clinical research.

Translated with www.DeepL.com/Translator

Hydroxycarboxylic acid receptor 2 mediates dimethy fumarate's protective effect in EAE